Transdiagnostic tailored internet- and mobile-based guided treatment for major depressive disorder and comorbid anxiety: Study protocol of a randomized controlled trial

Publikation: Beiträge in ZeitschriftenZeitschriftenaufsätzeForschungbegutachtet

Standard

Transdiagnostic tailored internet- and mobile-based guided treatment for major depressive disorder and comorbid anxiety : Study protocol of a randomized controlled trial. / Weisel, Kiona K.; Zarski, Anna Carlotta; Berger, Thomas; Schaub, Michael P.; Krieger, Tobias; Moser, Christian T.; Berking, Matthias; Ebert, David D.

in: Frontiers in Psychiatry, Jahrgang 9, Nr. JUL, 274, 04.07.2018.

Publikation: Beiträge in ZeitschriftenZeitschriftenaufsätzeForschungbegutachtet

Harvard

APA

Vancouver

Bibtex

@article{e4de193970ee4ec1ba52439e18e1bf87,
title = "Transdiagnostic tailored internet- and mobile-based guided treatment for major depressive disorder and comorbid anxiety: Study protocol of a randomized controlled trial",
abstract = "Introduction: Depression is highly prevalent and often accompanied by comorbid anxiety disorder. Internet-based interventions have shown to be one effective treatment modality; however, comorbidities are often not targeted. Transdiagnostic tailored internet-and mobile-based interventions (IMIs) might be promising to overcome such issues. Aim: This study aims to evaluate the efficacy, moderators, and cost-effectiveness of a transdiagnostic tailored internet- and mobile-based guided intervention for depression and comorbid anxiety in individuals with major depressive disorder (MDD). Method: Two-hundred participants with MDD will be randomly assigned to an 8-week guided self-help internet intervention (IC) or a 6-month wait-list control group (WLC). Participants of the IC will receive weekly content-focused feedback on module completion as well as monitored adherence reminders from an eCoach. The primary outcome is clinician-rated depression severity (QIDS-C) at post-assessment assessed by diagnostic raters blind to study condition. Secondary outcomes include, e.g., change in diagnostic status (MDD and anxiety disorders), remission and response rates, disorder symptom severity, health related quality of life, incongruence related to needs and values, and behavioral activation. Assessments will take place at baseline (T1), post-assessment (T2), 6-month follow-up (T3), and 12-month follow-up in the IC. Data will be analyzed on an intention-to-treat basis and per protocol. A large number of a priori defined moderators of treatment outcome will be assessed at baseline and tested in predicting treatment outcome. Cost-effectiveness will be evaluated from a societal perspective. Discussion: The present study will provide evidence on the efficacy, potential cost-effectiveness, and moderators of a transdiagnostic tailored guided internet- and mobile-based treatment protocol.",
keywords = "Anxiety, Comorbidity, Depression, Guided self-help, Internet intervention, Randomized controlled trial, Tailored, Transdiagnostic, Psychology",
author = "Weisel, {Kiona K.} and Zarski, {Anna Carlotta} and Thomas Berger and Schaub, {Michael P.} and Tobias Krieger and Moser, {Christian T.} and Matthias Berking and Ebert, {David D.}",
year = "2018",
month = jul,
day = "4",
doi = "10.3389/fpsyt.2018.00274",
language = "English",
volume = "9",
journal = "Frontiers in Psychiatry",
issn = "1664-0640",
publisher = "Frontiers Research Foundation",
number = "JUL",

}

RIS

TY - JOUR

T1 - Transdiagnostic tailored internet- and mobile-based guided treatment for major depressive disorder and comorbid anxiety

T2 - Study protocol of a randomized controlled trial

AU - Weisel, Kiona K.

AU - Zarski, Anna Carlotta

AU - Berger, Thomas

AU - Schaub, Michael P.

AU - Krieger, Tobias

AU - Moser, Christian T.

AU - Berking, Matthias

AU - Ebert, David D.

PY - 2018/7/4

Y1 - 2018/7/4

N2 - Introduction: Depression is highly prevalent and often accompanied by comorbid anxiety disorder. Internet-based interventions have shown to be one effective treatment modality; however, comorbidities are often not targeted. Transdiagnostic tailored internet-and mobile-based interventions (IMIs) might be promising to overcome such issues. Aim: This study aims to evaluate the efficacy, moderators, and cost-effectiveness of a transdiagnostic tailored internet- and mobile-based guided intervention for depression and comorbid anxiety in individuals with major depressive disorder (MDD). Method: Two-hundred participants with MDD will be randomly assigned to an 8-week guided self-help internet intervention (IC) or a 6-month wait-list control group (WLC). Participants of the IC will receive weekly content-focused feedback on module completion as well as monitored adherence reminders from an eCoach. The primary outcome is clinician-rated depression severity (QIDS-C) at post-assessment assessed by diagnostic raters blind to study condition. Secondary outcomes include, e.g., change in diagnostic status (MDD and anxiety disorders), remission and response rates, disorder symptom severity, health related quality of life, incongruence related to needs and values, and behavioral activation. Assessments will take place at baseline (T1), post-assessment (T2), 6-month follow-up (T3), and 12-month follow-up in the IC. Data will be analyzed on an intention-to-treat basis and per protocol. A large number of a priori defined moderators of treatment outcome will be assessed at baseline and tested in predicting treatment outcome. Cost-effectiveness will be evaluated from a societal perspective. Discussion: The present study will provide evidence on the efficacy, potential cost-effectiveness, and moderators of a transdiagnostic tailored guided internet- and mobile-based treatment protocol.

AB - Introduction: Depression is highly prevalent and often accompanied by comorbid anxiety disorder. Internet-based interventions have shown to be one effective treatment modality; however, comorbidities are often not targeted. Transdiagnostic tailored internet-and mobile-based interventions (IMIs) might be promising to overcome such issues. Aim: This study aims to evaluate the efficacy, moderators, and cost-effectiveness of a transdiagnostic tailored internet- and mobile-based guided intervention for depression and comorbid anxiety in individuals with major depressive disorder (MDD). Method: Two-hundred participants with MDD will be randomly assigned to an 8-week guided self-help internet intervention (IC) or a 6-month wait-list control group (WLC). Participants of the IC will receive weekly content-focused feedback on module completion as well as monitored adherence reminders from an eCoach. The primary outcome is clinician-rated depression severity (QIDS-C) at post-assessment assessed by diagnostic raters blind to study condition. Secondary outcomes include, e.g., change in diagnostic status (MDD and anxiety disorders), remission and response rates, disorder symptom severity, health related quality of life, incongruence related to needs and values, and behavioral activation. Assessments will take place at baseline (T1), post-assessment (T2), 6-month follow-up (T3), and 12-month follow-up in the IC. Data will be analyzed on an intention-to-treat basis and per protocol. A large number of a priori defined moderators of treatment outcome will be assessed at baseline and tested in predicting treatment outcome. Cost-effectiveness will be evaluated from a societal perspective. Discussion: The present study will provide evidence on the efficacy, potential cost-effectiveness, and moderators of a transdiagnostic tailored guided internet- and mobile-based treatment protocol.

KW - Anxiety

KW - Comorbidity

KW - Depression

KW - Guided self-help

KW - Internet intervention

KW - Randomized controlled trial

KW - Tailored

KW - Transdiagnostic

KW - Psychology

UR - http://www.scopus.com/inward/record.url?scp=85049826437&partnerID=8YFLogxK

U2 - 10.3389/fpsyt.2018.00274

DO - 10.3389/fpsyt.2018.00274

M3 - Journal articles

C2 - 30022954

AN - SCOPUS:85049826437

VL - 9

JO - Frontiers in Psychiatry

JF - Frontiers in Psychiatry

SN - 1664-0640

IS - JUL

M1 - 274

ER -

Dokumente

DOI